Medtronic | MDT
Stock Price
85.92
Daily Change
-0.07 -0.08%
Monthly
-5.20%
Yearly
8.76%
Q4 Forecast
88.76


Peers Price Chg Day Year Date
Terumo 3,086.00 -10.00 -0.32% -35.14% Nov/27
Abbott 117.96 -0.24 -0.20% 14.85% Nov/26
AtriCure 35.79 -0.22 -0.61% -14.79% Nov/26
Baxter International 32.85 -0.66 -1.96% -9.82% Nov/26
Becton, Dickinson and Co. 224.25 -1.32 -0.59% -6.12% Nov/26
Boston Scientific 90.21 0.95 1.07% 61.98% Nov/26
Cooper Companies 102.65 0.19 0.19% 22.61% Nov/26
Danaher 236.58 -0.87 -0.37% 7.54% Nov/26
Dexcom 77.96 -0.04 -0.05% -31.60% Nov/26
Edwards Lifesciences 71.56 0.32 0.45% 6.55% Nov/26
Globus Medical 84.53 0.04 0.05% 83.48% Nov/26
Hologic 79.00 -0.73 -0.92% 10.44% Nov/26
Integra LifeSciences 23.70 -0.54 -2.23% -38.73% Nov/26
Intuitive Surgical 542.21 5.37 1.00% 72.14% Nov/26
J&J 154.37 -1.38 -0.89% 2.04% Nov/26
Masimo 172.26 -5.44 -3.06% 80.79% Nov/26
Medtronic 85.92 -0.07 -0.08% 8.76% Nov/26
Merit Medical Systems 104.00 -0.92 -0.88% 44.91% Nov/26
Philips 25.76 -0.11 -0.43% 30.83% Nov/26
Insulet 266.42 -0.16 -0.06% 41.91% Nov/26
Smith & Nephew 985.60 2.40 0.24% -3.51% Nov/26
Stryker 389.57 4.80 1.25% 32.52% Nov/26
Teleflex 191.03 -3.04 -1.57% -12.71% Nov/26
Thermo Fisher Scientific 513.01 -0.69 -0.13% 4.67% Nov/26
Tandem Diabetes Care 30.04 -0.38 -1.25% 54.29% Nov/26
Zimmer Biomet Holdings 110.64 -0.32 -0.29% -2.81% Nov/26

Indexes Price Day Year Date
US500 6023 34.27 0.57% 32.24% Nov/27

Medtronic traded at $85.92 this Tuesday November 26th, decreasing $0.07 or 0.08 percent since the previous trading session. Looking back, over the last four weeks, Medtronic lost 5.20 percent. Over the last 12 months, its price rose by 8.76 percent. Looking ahead, we forecast Medtronic to be priced at 88.76 by the end of this quarter and at 84.96 in one year, according to Trading Economics global macro models projections and analysts expectations.

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The Company's subsidiaries include Medtronic, Inc. and HeartWare International, Inc.